Treace Medical Concepts Inc - Asset Resilience Ratio
Treace Medical Concepts Inc (TMCI) has an Asset Resilience Ratio of 22.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Treace Medical Concepts Inc's Asset Resilience Ratio has changed over time. Check Treace Medical Concepts Inc (TMCI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Treace Medical Concepts Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Treace Medical Concepts Inc market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.31 Million | 22.98% |
| Total Liquid Assets | $42.31 Million | 22.98% |
Asset Resilience Insights
- Good Liquidity Position: Treace Medical Concepts Inc maintains a healthy 22.98% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Treace Medical Concepts Inc Industry Peers by Asset Resilience Ratio
Compare Treace Medical Concepts Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Treace Medical Concepts Inc (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Treace Medical Concepts Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 19.76% | $37.66 Million | $190.58 Million | -9.87pp |
| 2024-12-31 | 29.63% | $64.33 Million | $217.09 Million | -14.12pp |
| 2023-12-31 | 43.75% | $110.22 Million | $251.91 Million | +4.90pp |
| 2022-12-31 | 38.85% | $61.78 Million | $159.02 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $140.82 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more